Smart Technology for Weight Loss and Metabolic Health
Study Details
Study Description
Brief Summary
The study will evaluate whether a technology-based lifestyle intervention program using primarily a smartphone platform is an acceptable and effective way for treating obesity. The goal of the program is to achieve weight loss and enhance the health of overweight or obese subjects by improving their diet and activity via smartphone applications as compared with conventional in-person weight management programs.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Smart Technology Group The Smart Technology Group will receive a technology-based lifestyle intervention program which uses wearable technology, smartscales and smartphone applications to track and deliver feedback on caloric expenditure, physical activity, caloric intake and body weight. Participants will receive information through smartphone applications on strategies to make changes to their diet, physical activity, and weight-related behaviors along with standard 3 monthly in-person weight management visits. |
Device: Wearable technology, smartscale
Behavioral: Smartphone applications
Behavioral: Standard Weight Management Visits
|
Other: Standard Weight Management Group The Standard Weight Management Group will receive 3 monthly in-person weight management visits during which they will receive standard of care lifestyle recommendations in accordance with the 2013 American Heart Association/American College of Cardiology/The Obesity Society Guideline. |
Behavioral: Standard Weight Management Visits
|
Outcome Measures
Primary Outcome Measures
- Change in body weight in kg [6 months]
Secondary Outcome Measures
- Change from baseline blood pressure [6 months]
- Change from baseline waist circumference [6 months]
- Change from baseline insulin resistance by homeostasis model assessment (HOMA-IR) [6 months]
- Change from baseline hemoglobin A1c [6 months]
- Change from baseline plasma triglycerides [6 months]
- Change from baseline body weight in kg [3 months]
- Change from baseline body weight in kg [12 months]
- Change from baseline blood pressure [12 months]
- Change from baseline waist circumference [12 months]
- Change in Quality of Life [6 months after receiving the intervention]
SF36 Questionnaire in wait-listed control group after the intervention
- Change in insulin resistance by homeostasis model assessment (HOMA-IR) [12 months compared to baseline and 6 months after receiving the intervention]
Wait-listed control group
- Change in hemoglobin A1c [12 months compared to baseline and 6 months after receiving the intervention and from baseline]
Wait-listed control group
- Change in plasma triglycerides [12 months compared to baseline and 6 months after receiving the intervention]
Wait-listed control group
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Overweight or obese BMI 25-42 kg/m2
-
Employed in sedentary occupations
-
Own a personal smartphone with unlimited data plan or >4 GigaByte data
-
Proficient with use of smartphone applications and technology with current daily usage
-
Ability to engage in moderate intensity exercise
-
Weight stability for the last 2 months
-
Participants must be willing to comply with all study-related procedures
Exclusion Criteria:
-
Current or planned pregnancy
-
Cardiovascular, pulmonary, renal disease, joint disease
-
Uncontrolled thyroid disease
-
History of eating disorders, psychiatric disease
-
History of substance abuse or dependence in the last 1 year
-
Diabetes
-
Shift work
-
Previous weight loss surgery
-
Use of weight loss drugs/diet/program in the last 6 weeks
-
Inability to increase walking as a form of exercise and to engage in moderate intensity exercise
-
Other conditions or medications that affect body weight/appetite/metabolism
-
Serious or unstable medical or psychological conditions that would compromise the subject's safety for successful participation
-
Incapable of adhering with an intensive lifestyle intervention using technology and smartphone applications
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Temple University | Philadelphia | Pennsylvania | United States | 19140 |
Sponsors and Collaborators
- Temple University
- The Obesity Treatment Foundation
Investigators
- Principal Investigator: Cherie Vaz, MD Dipl ABOM, Temple University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 23217